Before the approval decision date, the FDA issued a complete response letter, CRL last month asking for at least one more clinical trial in relieving DED symptoms. No questions were raised on safety.

Shares of Charles River Labs (CRL) crashed 28% after the U.S. FDA (Food and Drug Administration) announced plans to phase out the need for animal testing in developing drugs like monoclonal ...

In this article, we are going to take a look at where Charles River Laboratories International, Inc. (NYSE:CRL) stands against other stocks that traders heavily sold down on Thursday. The stock ...

In this article, we are going to take a look at where Charles River Laboratories International, Inc. (NYSE:CRL) stands against other mid-cap stocks insiders were buying in Q1 2025. Stock markets ...

In trading on Tuesday, shares of Charles River Laboratories International Inc. (Symbol: CRL) entered into oversold territory, hitting an RSI reading of 29.8, after changing hands as low as $105.18 ...